02197

1.34010.67%
YL

Yang Li

Chief Technology Officer

Dr. Yang Li, Ph.D., serves as Chief Technology Officer at Clover Biopharmaceuticals, Ltd. since 2023 and had been its Senior Vice President of Process Development and Manufacturing Science (PDMS) since December 2021 until 2023 with experience in biologic therapeutics process and product development. Prior to Clover, Dr. Li was the VP, CMC Head of Overland Pharma Shanghai China. Prior to that, Dr. Li assumed VP/CMC head, Senior Scientist, and Scientist positions at Lyvgen Biopharma, Celgene Corporation, and Bristol-Myers Squibb, respectively. Dr. Yang Li obtained his Ph.D degree in Bioengineering from Massachusetts Institute of Technology.

Positions